Abstract
Objective: To analyze the application value of misoprostol tablets in painless abortion. Methods: 40 patients who received painless abortion from January 2022 to August 2023 were randomly divided into two groups; those who received misoprostol tablets before the operation were included in group A, and those who did not use misoprostol tablets before the operation were included in group B. Differences in cervical laxity, cervical dilatation time, uterine aspiration time, surgical blood loss, complications, and satisfaction were recorded. Results: The excellent and good rate of cervical dilation in group A was higher than that in group B (P < 0.05); the dilatation time, uterine suction time, surgical blood loss, and other indicators in group A were better than those in group B (P < 0.05); the complication rate after abortion in group A was lower than that of group B (P < 0.05); satisfaction rate in group A was higher than that of group B (P < 0.05). Conclusion: Oral administration of misoprostol tablets before painless abortion can relax the cervix, shorten the dilation time of the cervix, reduce intraoperative bleeding, and have higher patient satisfaction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
